Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J.P. Morgan Notebook Day 2: Walmsley On Diversity, Amgen's Overseas Cash, Growing Opdivo, Mylan On US Generic Pricing, Boston's Pipeline And J&J In Alzheimer's

Executive Summary

Daily round-up of news and notes from the 2018 J.P. Morgan Healthcare Conference in San Francisco: GSK's Walmsley looks to be a leader on diversity, Amgen talks tax reform and deals, Mylan raises the issue of generic drug shortages, Boston builds out its pipeline, and J&J is dealing in Alzheimer's disease.

Advertisement

Related Content

Deal Watch: As J.P. Morgan Waits For New Deals, Sanofi Takes Care Of Old Business
J.P. Morgan Notebook Day 1: Tax Reform At Last, Allergan's Job Cuts, Teva Turnaround, Biogen's Cash, And Getting FDA-Friendly
PD-1 Earnings Roundup: Buckle Up For A Bumpy Ride
Amgen Focuses On Pipeline As Mature Products Face Declining Demand
Alzheimer's Prevention: The Next Big Idea For Fixing Drug Trial Failures
Disappointed, Yes, But Roivant's Not Roiled By Axovant's Alzheimer's Failure
From Witty To Walmsley – The Priorities For GSK's New CEO
Another Nail In Amyloid Hypothesis Coffin? Merck Ends Pivotal BACE Inhibitor Study
Viehbacher On Boston Pharmaceuticals: A New Model To De-Risk Drugs
California Dreaming: J&J Builds Bay Area Ties With Second Startup Home

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS122277

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel